查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439199

全球生化自动诊断市场评估：按组件、仪器类型、应用、最终用户、地区、机会和预测（2017-2031）

Biochemical Auto-Diagnostics Market Assessment, By Component, By Instrument Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5个工作天内

价格

全球生化自动化诊断市场规模预计将从 2023 年的 50.1 亿美元增至 2031 年的 78.1 亿美元，2024-2031 年预测期间复合年增长率为 5.7%。这个市场主要是由对快速、准确的诊断测试不断增长的需求所推动的。实验室程序的自动化、对疾病早期诊断的重视以及生化诊断技术的进步正在成为其他成长动力。慢性病和传染病导致的疾病负担迅速增加，对自动化诊断程序的需求显着增加，进一步扩大了该市场的范围。老化人口的增加，更容易感染疾病，也增加了对诊断的需求。有关当局对诊断技术扩展的监管支持将进一步推动市场成长。

然而，由于购买和操作自动生化分析仪的成本高昂，实验室的易拥有性已成为一个问题，这也是製造商面临的主要挑战之一。抵制采用新技术和缺乏适当的培训模组也是公司目前面临的主要挑战。

2023年6月，Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（Mindray）推出高通量M1000 Chemistry and Immunoassay Integrated Solution。该解决方案包括BS-2800M Chemistry Analyzer、CL-8000i Chemiluminescence Immunoassay Analyzer和智慧样品输送模组。

对快速、准确的诊断测试的需求不断增长

非传染性疾病的流行、人口老化以及立即医疗诊断、筛检和监测的需要等因素推动了对快速、准确的诊断测试的需求不断增长。由于慢性病盛行率的增加和人口老化，对诊断测试的需求持续增加。随着即时医疗诊断和调查需求的增加，对先进分析设备和创新技术的需求也会增加。为此，临床生化分析仪的技术创新不断进步，使得更早发现疾病并进行更大规模的检测成为可能。自动化诊断生化分析仪和耗材可以轻鬆满足不断增长的诊断需求，进一步扩大市场。製造商正在积极致力于生产快速、精确的生化分析仪的解决方案。

例如，2023 年 5 月，Beckman Coulter推出了DxI 9000 Access Immunoassay Analyzer。DxI 9000 分析仪每小时每平方公尺可进行多达 215 次测试，是占地面积方面效率最高的免疫分析仪。Beckman Coulter是全球先进诊断解决方案的领先供应商。

测试程序的快速自动化

实验室程序的快速自动化正在增加对自动化生化分析仪的需求。随着诊断实验室变得越来越自动化，先进的设备可以执行数百到数千次测试。因此，对自动化分析设备的需求不断增加。自动化提供快速、经济高效且高品质的测试，这对于满足不断增加的样本量和临床实验室卓越运作的需求至关重要。几十年来，自动化也一直是大多数临床化学工作流程不可或缺的一部分，使实验室能够处理更多的测试请求并降低成本。

2023 年 7 月，Beckman Coulter推出了美国 FDA 批准的用于免疫分析诊断的Atellica CI Analyser。Atellica CI Analyser使独立实验室和卫星实验室能够存取与 Atellica 解决方案相同的试剂、耗材和智慧软体。该技术设计适合 1.9 平方米的小空间，非常适合空间有限的实验室。透过实现随机取样、微抽吸以及自动安排维护和品质控制，实验室可以提供更可靠、更及时的结果。

本报告研究和分析了全球生化自动化诊断市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法论

第二章 专案范围与定义

第3章执行摘要

第四章 全球自动化生化诊断市场展望（2017-2031）

  • 市场规模及预测
    • 金钱数额
    • 数量
  • 按组件
    • 用具
    • 试剂
    • 消耗品
  • 依夹具类型
    • 全自动生化分析仪
    • 半自动生化分析仪
  • 按用途
    • 临床诊断
    • 生物反应器副产物检测
    • 药物开发应用
    • 其他
  • 按最终用户
    • 医院
    • 诊断中心
    • 製药公司、生技公司
    • 学术研究所
    • 开发合约组织
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 市场占有率：依公司划分（2023 年）

第五章全球生化自动化诊断市场前景：按地区划分（2017-2031）

  • 北美
    • 市场规模及预测
    • 按组件
    • 依夹具类型
    • 按用途
    • 按最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 土耳其
    • 俄罗斯
    • 荷兰
    • 波兰
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 越南
    • 印度尼西亚
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 南非

第六章 市场测绘（2023）

  • 按组件
  • 依夹具类型
  • 按用途
  • 按最终用户
  • 按地区

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

  • 增长动力
  • 成长限制因素（问题、限制因素）

第九章 监理架构与创新

  • 专利情况
  • 监管审批
  • 创新/新技术

第十章 主要公司情况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名市场领导者的市场收入分析（2023 年）
  • 併购/合资（如适用）
  • SWOT分析（5家进入市场的公司）

第11章价格分析

第十二章案例研究

第十三章 主要公司展望

  • Roche Diagnostics GmbH
  • Sysmex Corporation
  • Sartorius AG
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Beckman Coulter Inc.
  • Abbott Diagnostics Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Hologic, Inc.

第十四章 战略建议

第十五章 关于我们公司、免责声明

Product Code: MX11035

Global biochemical auto-diagnostics market is projected to witness a CAGR of 5.7% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 7.81 billion in 2031. The growing demand for rapid and accurate diagnostic tests primarily drives the biochemical auto-diagnostics market. Automation of laboratory procedures, emphasis on early diagnosis of diseases, and advancements in technologies used for biochemistry diagnostics are acting as other growth-inducing factors. The rapidly growing disease burden of chronic and infectious diseases significantly raises the demand for automated diagnostics procedures, further expanding the scope of this market. The growing geriatric population, which is most prone to catching diseases, increases the demand for diagnostics. Regulatory support from concerned authorities for technology expansion in diagnostics further boosts the market growth.

However, the high cost of purchasing and operating the automated biochemistry analyzer raises affordability issues for laboratories, which is one of the major challenges for the manufacturers. A significant challenge also comes from resistance to adopting new technology and a lack of suitable training modules, although companies are working on this now.

In June 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray) launched the high-throughput M1000 Chemistry and Immunoassay Integrated Solution. The solution includes the BS-2800M Chemistry Analyzer, CL-8000i Chemiluminescence Immunoassay Analyzer, and an intelligent sample delivery module.

Growing Demand for Rapid and Accurate Diagnostic Tests

The growing demand for rapid and accurate diagnostic tests is driven by factors such as the rising prevalence of noncommunicable diseases, an aging population, and the need for immediate medical diagnosis, screening, and surveillance. The demand for diagnostic testing continues to rise due to the increasing prevalence of chronic conditions and the aging population. As the need for immediate medical diagnosis and surveillance increases, the demand for advanced analyzers and innovative technologies rises. This has led to technological innovations in clinical chemistry analyzers, enabling early disease detection and testing on a larger scale. The growing demand for diagnostics can be easily catered to through auto-diagnostics biochemistry analyzers and consumables, further expanding the market. Manufacturers are actively involved in producing solutions for rapid and precise biochemistry analyzers.

For instance, in May 2023, Beckman Coulter unveiled the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Analyzer can perform up to 215 tests per hour per square meter, making it the most productive immunoassay analyzer in terms of footprint. Beckman Coulter is a leading provider of advanced diagnostics solutions across the globe.

Rapid Automation of Laboratory Procedures

The rapid automation of laboratory procedures has increased the demand for automated biochemistry analyzers. As diagnostic laboratories become more automated, sophisticated instruments can complete hundreds to thousands of tests. This has led to an increased demand for automated analyzers. Automation allows for fast, cost-efficient, and high-quality testing, essential to meet the growing sample load and the need for operational excellence in clinical laboratories. Additionally, automation has been an integral part of most clinical chemistry workflows for decades, allowing labs to handle many test requests and reduce costs.

In July 2023, Siemens Healthineers launched a US-FDA-approved Atellica CI Analyser for immunoassay diagnostics. The Atellica CI Analyzer allows standalone and satellite labs to access the same reagents, consumables, and intelligent software as Atellica Solution. This technology has been designed to fit into a small 1.9m2 space, perfect for laboratories with limited space. It allows labs to provide more reliable and timely results by allowing random access sampling, micro-volume aspiration, and automatic scheduling of maintenance and quality control.

Dominance of Fully Automatic Biochemistry Analyzers Segment

Fully automatic biochemistry analyzers are preferred over semi-automatic ones for several reasons. One of the primary advantages is that fully automatic analyzers require little or no manual intervention, reducing the potential for human error. They can also handle a higher throughput of samples, making them more suitable for larger laboratories with high testing volumes. Additionally, fully automatic analyzers offer more automation, from sample addition to result reporting, leading to improved efficiency and streamlined testing processes. Furthermore, the test results of fully automatic analyzers are generally more accurate and convenient than semi-automatic analyzers. Fully automatic analyzers are ideal for high sample volumes and efficient processing, semi-automatic analyzers may be sufficient for smaller laboratories or point-of-care settings with lower sample volumes and can accommodate a slightly longer turnaround time.

In July 2023, Anbio launched a fully automated CLIA analyzer. The Anbio ADL i1910 is an affordable and compact chemiluminescence immunoassay analyzer that provides a comprehensive range of testing options for analytes in human serum, plasma, whole blood, and urine samples. It uses the direct chemiluminescence method to ensure accurate and reliable hormone detection, disease screening, and antigen analysis results.

Hospitals to Lead the End-user Segment

Hospitals use biochemical analyzers for various purposes, including routine check-ups, disease screening, confirmation tests, and diagnosis of different ailments. These analyzers are critical for assessing chemicals in biological samples, analyzing analytes such as proteins, electrolytes, enzymes, and metabolites, and evaluating the performance of organs like the liver, heart, and kidneys. They are also helpful in drug monitoring, detecting drug misuse, and diagnosing infectious diseases. The growing demand for diagnostic testing has led to an increase in the usage of biochemical analyzers, making hospitals one of the primary consumers of these devices. Market players are designing products to cater to the specific requirements of hospitals.

In May 2023, Wondfo launched the Ucare-6000 Automatic Blood Gas Biochemical Analyzer at the 20th China Association of Clinical Laboratory Practice Expo (CACLP). The Ucare-6000 automatic blood gas biochemical analyzer offers accuracy, efficiency, flexibility, and simplified operation. It uses electrochemistry sensing technology, microfluidic technology, and thin-film microelectrode technology. With its sound QC system, it can perform automatic calibration and internal QC to ensure accurate results.

North America to be the Dominating Region

North America is the leading consumer of biochemistry analyzers due to the rising prevalence of chronic diseases, such as diabetes and cardiovascular disorders, which require efficient diagnostic tools to manage and monitor these conditions. The need for rapid and on-site diagnostic solutions is also driving the demand for biochemistry analyzers, and the trend toward miniaturization is contributing to cost-effectiveness. The United States is a significant market for biochemistry analyzers, with high investments in research and development initiatives. The presence of key market players like Beckman Coulter Inc., and Abbott Diagnostics Inc. in the region also contributed to the region's dominance in this market.

Future Market Scenario (2024 - 2031F)

The major drivers of the market include digital transformation for labs, increasing research and development activities across the healthcare industry, and growing expenditure on the diagnostics industry.

The growing affinity of healthcare providers for adopting technology-based solutions for diagnostics is anticipated to increase the demand for the biochemical auto-diagnostics market.

Fully automated biochemical analyzers are preferred over semi-automated biochemical analyzers due to enhanced efficacy and efficiency and are expected to be the dominating segment throughout the assessment period.

Hospitals are anticipated to be the leading end-users for this market due to the growing requirement for rapid diagnostic tests, owing to the high disease burden and growing geriatric population.

Key Players Landscape and Outlook

The key players in the landscape of the biochemical auto-diagnostics market include companies involved in the manufacturing and distribution of biochemistry analyzers and biochemical diagnostic instruments. Some prominent companies in this market are Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., and Abbott Diagnostics. These companies are known for their advanced healthcare technologies and have a significant market presence. The market is expected to witness healthy competition with the integration of new technologies.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced the acquisition of a 75% stake in Germany-based DiaSys Diagnostic Systems GmbH, this acquisition makes DiaSys, a subsidiary of Mindray. The acquisition will expand the IVD offerings of Mindray including the biochemical analyzers.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biochemical Auto-Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Component
    • 4.2.1. Instruments
    • 4.2.2. Reagents
    • 4.2.3. Consumables
  • 4.3. By Instrument Type
    • 4.3.1. Fully Automatic Biochemistry Analyzers
    • 4.3.2. Semi-Automatic Biochemistry Analyzers
  • 4.4. By Application
    • 4.4.1. Clinical Diagnostics
    • 4.4.2. Bioreactor Byproduct Detection
    • 4.4.3. Drug Development Applications
    • 4.4.4. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Diagnostic Centers
    • 4.5.3. Pharmaceutical and Biotechnology Companies
    • 4.5.4. Academic Research Institutes
    • 4.5.5. Contract Research Organizations
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Biochemical Auto-Diagnostics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Component
      • 5.1.2.1. Instruments
      • 5.1.2.2. Reagents
      • 5.1.2.3. Consumables
    • 5.1.3. By Instrument Type
      • 5.1.3.1. Fully Automatic Biochemistry Analyzers
      • 5.1.3.2. Semi-Automatic Biochemistry Analyzers
    • 5.1.4. By Application
      • 5.1.4.1. Clinical Diagnostics
      • 5.1.4.2. Bioreactor Byproduct Detection
      • 5.1.4.3. Drug Development Applications
      • 5.1.4.4. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Diagnostic Centers
      • 5.1.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.5.4. Academic Research Institutes
      • 5.1.5.5. Contract Research Organizations
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Component
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.2. Reagents
      • 5.1.6.2.3. Consumables
      • 5.1.6.3. By Instrument Type
      • 5.1.6.3.1. Fully Automatic Biochemistry Analyzers
      • 5.1.6.3.2. Semi-Automatic Biochemistry Analyzers
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Clinical Diagnostics
      • 5.1.6.4.2. Bioreactor Byproduct Detection
      • 5.1.6.4.3. Drug Development Applications
      • 5.1.6.4.4. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Diagnostic Centers
      • 5.1.6.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.4. Academic Research Institutes
      • 5.1.6.5.5. Contract Research Organizations
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. United Kingdom
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Turkey
    • 5.2.7. Russia
    • 5.2.8. Netherlands
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Australia
    • 5.3.6. Vietnam
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Component
  • 6.2. By Instrument Type
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Roche Diagnostics GmbH
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Sysmex Corporation
  • 13.3. Sartorius AG
  • 13.4. Merck KGaA
  • 13.5. Thermo Fisher Scientific Inc.
  • 13.6. Siemens AG
  • 13.7. Beckman Coulter Inc.
  • 13.8. Abbott Diagnostics Inc.
  • 13.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 13.10. Hologic, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 4. Global Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 5. Global Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Biochemical Auto-Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 11. North America Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 12. North America Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 18. United States Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 19. United States Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 24. Canada Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 25. Canada Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 30. Mexico Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 31. Mexico Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 36. Europe Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 37. Europe Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 43. Germany Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 44. Germany Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 49. France Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 50. France Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 51. France Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 55. Italy Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 56. Italy Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 61. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 62. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 67. Russia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 68. Russia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 73. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 74. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 79. Spain Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 80. Spain Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 85. Turkey Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 86. Turkey Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 91. Poland Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 92. Poland Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 97. South America Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 98. South America Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 104. Brazil Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 105. Brazil Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 110. Argentina Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 111. Argentina Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 116. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 117. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 123. India Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 124. India Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 125. India Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 129. China Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 130. China Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 131. China Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 135. Japan Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 136. Japan Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 141. Australia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 142. Australia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 147. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 148. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 153. South Korea Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 154. South Korea Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 159. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 160. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 165. Philippines Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 166. Philippines Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 171. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 172. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 178. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 179. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 184. UAE Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 185. UAE Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 190. South Africa Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 191. South Africa Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Instrument Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023